Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
| 21 | DE file number | DAKZ | P 37 75 229.4 |
| 96 | EP file number | EAKZ | 87 81 0080.9 |
| 97 | EP publication number | EPN | 233154 |
| 54 | Designation/title | TI | Ungesättigte Aminosäuren. |
| 51 | IPC main class | ICM
(ICMV) | C07F 9/38 (2000.01) |
| 51 | IPC secondary class(es) | ICS
(ICSV) | A61K 31/66 (2000.01), C07F 9/30 (2000.01), C07F 9/32 (2000.01), C07F 9/40 (2000.01), C07F 9/48 (2000.01) |
| 22 | DE application date | DAT | Feb 10, 1987 |
| 96 | EP application date | EAT | Feb 10, 1987 |
| 43 | Date of first publication | OT | Sep 24, 1987 |
| Date of publication of grant | PET | Dec 18, 1991 |
| 71/73 | Applicant/owner | INH | Novartis AG, 4056 Basel, CH |
| 72 | Inventor | IN | Angst Dr., Christof, Summit New Jersey, US; Brundish Dr., Derek Edward, Hosham West Sussex RH13 6DU, GB; Dingwall Dr., John Grey, CH-4412 Nuglar, CH; Fagg Dr., Graham Eric, CH-4125 Riehen, CH |
| Address for service | | Novartis AG, 4056 BASEL, CH |
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| CH
578/86
Feb 13, 1986
|
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | DE - Deutsch |
| 84 | Designated EP contracting states | EDS | AT, BE, CH, DE, ES, FR, GB, GR, IT, LI, LU, NL, SE |
| 43 | Date of first publication | EVT | Aug 19, 1987 |
| Date of the first transfer into DPMAregister | EREGT | Sep 25, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Jan 19, 2013
(Show all update days)(Hide all update days)- Jan 19, 2013
- Historical data not available for this/these date(s)
- Sep 25, 2012
- Date of the first transfer into DPMAregister
|
